drugset / Trial / NCT00689559

Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects

NCT00689559

Phase 1 Completed 52 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of the study is to evaluate if AZD3480 and warfarin interact with each other or not, i.e. show the same or altered plasma concentration profiles when co-administered compared to administered alone.

Timeline

Start
2008-03
Primary completion
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified
Subject ispronicline Small molecule Oral

Indications